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2732 | Anal. Methods, 2017, 9, 2732–27ix derivatizing agents for the
determination of nine synthetic cathinones using
gas chromatography-mass spectrometry
Khalid A. Alsenedi a and Calum Morrisonb
Six acylation reagents have been compared for their derivatisation potential towards nine synthetic cathinones by
gas chromatography-mass spectrometry (GC-MS). The evaluated reagents were pentaﬂuoropropionic
anhydride (PFPA), triﬂuoroacetic anhydride (TFA), chlorodiﬂuoroacetic anhydride (CLF2AA), heptaﬂuorobutyric
anhydride (HFBA), acetic anhydride (AA) and propionic anhydride (PA). The synthetic cathinones included
ﬂephedrone (4-ﬂuoromethcathinone or 4-FMC), mephedrone (4-methylmethcathinone or 4-MMC),
pentedrone (also known as a-methylamino-valerophenone), methedrone (4-methoxy-N-methcathinone, p-
methoxymethcathinone), methylone (3,4-methylenedioxy-N-methylcathinone or bk-MDMA), butylone (b-
keto-N-methylbenzodioxolylbutanamine or bk-MBDB), ethylone (3,4-methylenedioxy-N-ethylcathinone
MDEC or bk-MDEA), pyrovalerone (4-methyl-b-keto-prolintane) and 3,4-methylenedioxypyrovalerone
(MDPV). The derivatizing agents were optimised for incubation time and temperature with some important
validation parameters studied to evaluate derivatisation reactions. The anhydrides studied proved to be
suitable for synthetic cathinones – all of them showing RSD and accuracy below 20%. PFPA and HFBA
followed by TFA are the best choice of derivatising agents based on validation parameters. Five internal
standards were evaluated with good results. Three way ANOVA, interference, fragmentation patterns and high
peak area values at a concentration of 0.50 mg ml1 were evaluated and discussed. AA and PA derivatives give
high relative abundance for most drugs examined. HFBA gives more ions and multi-fragmentation patterns.Introduction
Cathinone (b-Keto-amphetamine) is found in the leaves of the
Catha edulis (Khat) plant.1 Synthetic cathinones have similar
properties to other stimulants and hallucinogenic drugs
including amphetamines and ring-substituted amphetamines.
They have pharmacological eﬀects, known as “cardiovascular
and neurological side-eﬀects”, and can cause deaths, many of
which have occurred in Europe.2–5 Despite the misuse potential
associated with these compounds, the legislation governing
their use is not consistent worldwide. Additionally, due to
chemical modications, these new psychoactive substances
(NPS) are rapidly altered to produce new variants to bypass drug
legislations of a particular country6,7 with detection and iden-
tication of these drugs proving diﬃcult because of a lack of
reference standards.8
A review by Zuba and colleagues discussed pathways and
unknown structures of cathinones based onmass spectrometry9edicine, Dentistry and Nursing, College of
versity of Glasgow, Glasgow, G12 8QQ,
il.com
edicine, Dentistry and Nursing, College of
versity of Glasgow, Glasgow, G12 8QQ,
lasgow.ac.uk
43with the isomers of substituted cathinones having been inves-
tigated using NMR spectroscopy by Kavanagh.10 More than 70
synthetic cathinones have been reported by the European
Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
with synthetic cathinones making up the second biggest
portion of NPS identied in 2015.11,12
The GC analysis of cathinones generally requires the use of
derivatising reagents. To select an appropriate derivatization
reagent for GC analysis, the following criteria can be used as
guidance:13
(a) The reagent should generate >95% of complete
derivatives.
(b) During derivative formation, the reagent should not alter/
rearrange the structure of the compound.
(c) Loss of sample should not occur during the reaction.
(d) Derivatives produced should not interact with the GC
column.
(e) A stable derivative should be formed.
To achieve the above goals, acylation was selected for this
study instead of other common derivatization methods (e.g.
silylation and alkylation) since it is a popular derivatising
technique widely used to increase the sensitivity, produce
excellent fragmentation in mass spectra, improve the chro-
matographic peak shape and resolution as well as reduction in
the polarity of analytes. PFPA, TFA, CLF2AA, HFBA, AA, and PAThis journal is © The Royal Society of Chemistry 2017
Fig. 1 Chemical structures of selected derivatisation agents.
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View Article Onlinewere the chosen acylation reagents in this study (see Fig. 1 for
the chemical structures of reagents).
The rst problem encountered with analysis of synthetic
cathinones is that during GCMS method development several
cathinones have only one or two important ions in the mass
spectrum. Most of the remaining ions have smaller abundance
(<10%) when compared with the highest abundance ion,
consequently resulting in poor detection. Secondly, some
cathinones have positional isomers, which produce ambiguous
mass spectra. Thirdly, MDPV and pyrovalerone are not deriva-
tised, and the analyst is dependent on a limited number of mass
ions. Fourthly, some cathinones have overlap between the high
abundance ions and those from internal standards. Taking
these factors into account with additional legal implications,
derivatisation techniques are necessary to produce many
patterns and high abundance resolution of fragmentations
aiding correct identication of these compounds.
In this study, the evaluation and comparison of these
reagents for selected cathinones were investigated with the
focus on the following:
+ Eﬀect of time and temperature on the reaction and opti-
mising these conditions.
+ Examination of the highest values of peak areas.
+ Quality of fragmentation ions vs. reagents.
+ Quality of mass spectrum based on its relative ion
intensities.
+ Total ion chromatograms from interference studies.
+ Data treatment analysis by running ANOVA.14
+ Choice of best-t regression between internal standards.
Some validation parameters including the LOD, linearity,
accuracy, RSD, and recovery were used.
Mephedrone, ephedrone, pentedrone, methylone, ethyl-
one, methedrone, MDPV, butylone, and pyrovalerone are the
most frequently abused cathinones in the UK and in Europe
and therefore selected as the target analytes15 (see Table 1).
Materials and methods
Materials
Reference standards of the nine synthetic cathinones (1 mg
ml1) – ephedrone, mephedrone, pentedrone, methedrone,
methylone, butylone, ethylone, pyrovalerone, and MDPV; ve
internal standards (0.10 mg ml1) – mephedrone-d3, methyl-
one-d3, butylone-d3, ethylone-d5 and MDPV-d8 as their hydro-
chloride salts; seven derivatization agents – pentauoro-
propionic anhydride (PFPA) $ 99%, triuoro-acetic anhydride
(TFA) $ 99%, chloro di-uoro acetic anhydride (CLF2AA) $
98%, heptauoro-butyric anhydride (HFBA) $ 99%, acetic
anhydride (AA) $ 99%, propionic anhydride (PA) $ 99%, andThis journal is © The Royal Society of Chemistry 2017butyric anhydride (BA) $ 98% were purchased from Sigma-
Aldrich, Gillingham, UK. Ethyl acetate (EtOAc), methanol,
ammonium hydroxide, sodium phosphate dibasic, sodium
chloride, sodium phosphate monobasic, dichloromethane
(DCM), isopropanol (IPA), ammonium hydroxide (NH4OH), and
acetic acid were obtained from VWR International, East Grin-
stead, UK. Blank blood was supplied by the Scottish National
Blood Transfusion Service based at Gartnaval Hospital, Glas-
gow. Phosphate buﬀer and sodium phosphate were purchased
from Fisher Scientic, Loughborough, UK. Solid phase extrac-
tion columns (200 mg clean screen® part number ZSDAU20
manufactured by United Chemical Technologies) were
purchased from Chromatography Direct, Runcorn, UK.Methods
Preparation of standards
Stock solutions (100 mg ml1) of the nine drugs were prepared
by dilution of the purchased standards via 1 : 10 dilution in
methanol. The working solution of each standard was prepared
by dilution of stock solutions 100 mg ml1 via 1 : 10 methanol to
reach 10 mg ml1. Working internal standards of the deuterated
standards were similarly prepared taking into account the
diﬀerent concentrations of the supplied standards.Optimisation of temperature and incubation time study
For optimisation of the reaction temperature and incubation
time within the study, cathinones were derivatised at the same
time in the following way: 50 ml of the 10 mg ml1 standard drug
mixture and 50 ml of 2 mg ml1 of mixture of internal standards
were added to samples. Then the mixture was evaporated to
dryness at Room Temperature (RT) under a stream of nitrogen
followed by derivatisation with 50 ml of PFPA and EtOAc (2 : 1);
50 ml of TFA and EtOAc (2 : 1); 50 ml CLF2AA and EtOAc (2 : 1); 65
ml of HFBA and EtOAc (3 : 2), AA and EtOAc (3 : 2), and PA and
pyridine (2 : 1). All samples were capped and vortexed imme-
diately for 15 seconds and then incubated for specic times (5–
10–15–20–25–30–35–40 min) and at specic temperatures (RT,
40 C, 55 C, 70 C). The samples were evaporated under
a stream of nitrogen with the hot block set at RT, 40 C and
50 C thereaer reconstituted in 50 ml of ethyl acetate. The top
layer of EtOAc was transferred to an auto-sampler vial for GC-
MS analysis. The GC syringe was washed three times before
injection in EtOAc. A volume of 1.0 ml was injected at 225 C and
GC-MS was run under the conditions outlined below.
Samples were prepared in triplicate on eight days at
concentrations of 0.50 mg ml1 and 0.10 mg ml1 for internal
standards. From day one to four, 72 samples (18 samples forAnal. Methods, 2017, 9, 2732–2743 | 2733
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Table 4 Three way ANOVA shows if there is signiﬁcant diﬀerence or
not when incubation time and temperatures were changed in the
procedure
Drug name/derv. PFPA TFA CLF2AA HFBA AA PA
Flephedrone Yes No No No No Yes
Mephedrone Yes No Yes No Yes Yes
Pentedrone No No Yes No No Yes
Methedrone No No No Yes Yes Yes
Methylone No No Yes Yes No Yes
Butylone No No Yes Yes No Yes
Ethylone No No No Yes No Yes
Pyrovalerone No No No No No Yes
MDPV No No No No No Yes
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View Article Onlineeach temperature) were added each day at RT, 40 C, 55 C and
70 C respectively and set of the same time at 10, 20, 30, and 40
minutes for each derivatization reagent. From day ve until day
eight, samples were set in the same way as previous days;
however, the times were changed to 5, 15, 25, and 35 minutes.
Each temperature and each incubation time were analysed in
triplicate. The samples were evaporated under a stream of
nitrogen at RT for all reagents on days 1, 2, 3 and 4. The
temperature on days 5, 6, 7 and 8 for PFPA, TFA and HFBA was
RT, while 40 C was used for AA and ClF2AA and 50 C for PA.
The 72 samples (18 samples for each temperature) under
nitrogen gas were also evaluated using a TurboVap® in the
following way: triplicate samples were run in one day when the
hot block was set at 50 C and the period of incubation was 20
minutes under RT, 40, 55 and 70 C.
A diﬀerent procedure was carried out to examine the eﬀect
of pyridine as a solvent in BA and PA in the following way: 200
ml of 10 mg ml1 from the mixtures of cathinones was added
followed by evaporation at RT. The triplicates of 18 derivat-
ized samples of BA and PA were closed and vortexed for 15
seconds and then incubated at 90 C for 30 minutes and then
in the evaporation step the samples were set at RT, 40 and
50 C.
54 samples were set in the same way as mentioned above in
one day to evaluate the reaction at RT, 55 C, and 70 C in
30 minutes (18 samples for each temperature). The evaporation
step was set at RT. Again, each temperature was analysed in
triplicate.Optimisation procedure
The optimisation procedure for the incubation time and the
temperature of the hot block were as follows: PFPA and TFA
were set at RT and 40 C, respectively, for 20 min; the hot block
was set at RT; ClF2AA and HFBA were set at 55 C for 25 min; the
hot block was set at 40 C; AA and PA were set at 70 C for
20 min; and the hot block was set at 50 C.
The above procedures were used in this study to calculate
peak areas, relative standard deviation (RSD), accuracy values
and signicant diﬀerences between the reaction temperature
and time using ANOVA.Table 3 Optimisation of temperature and incubation time. This is accord
of 0.50 mg ml1. The temperature between the brackets is the optimised
Drug name/derv. PFPA (RT) TFA (RT) CLF2AA
Flephedrone 20 min RT 20 min 40 C 20 min
Mephedrone 10 min RT 20 min 40 C 25 min
Pentedrone 20 min RT 20 min 40 C 25 min
Methedrone 20 min 40 C 20 min 40 C 25 min
Methylone 35 min 70 C 20 min 40 C 25 min
Butylone 20 min 40 C 20 min 40 C 25 min
Ethylone 20 min 40 C 20 min 40 C 25 min
Pyrovalerone 35 min 70 C 25 min 70 C 25 min
MDPV 35 min 70 C 25 min 70 C 25 min
Optimisation 20 min RT 20 min 40 C 25 min
2736 | Anal. Methods, 2017, 9, 2732–2743Study of linearity, LOD, recovery and internal standards
For linearity, the samples were prepared in triplicate and spiked
with cathinones at seven concentrations (2, 1, 0.75, 0.50, 0.25,
0.10, and 0.05) mg ml1, covering the range in which a common
stimulant (amphetamine) is commonly encountered within
toxicological samples.
For the LOD, the samples were prepared in triplicate and spiked
at seven concentrations (250, 100, 50, 25, 10, 5, and 1 ng ml1).SPE method used for recovery study
1 ml of whole blood of each sample was added and mixed with
1 ml of 0.10 M phosphate buﬀer (pH ¼ 6), and all samples were
then mixed and centrifuged. The extraction column was
conditioned using 3 ml of methanol, followed by 3 ml deionized
water and then 1 ml of 0.10 M phosphate buﬀer at pH 6 for
washing the cartridges and removing unwanted substances.
The samples were added and allowed to pass through the
columns completely. Washing consisted of addition of 3 ml of
deionized water, followed by 1 ml of 100 mM acetic acid and
then 3 ml methanol followed by drying under full vacuum for 5
minutes. The samples were eluted with 3 ml of
DCM : IPA : NH4OH (78 : 20 : 2), and then evaporated under
a stream of nitrogen at RT until dry. The dried extracts were
then derivatised in the same way as mentioned above in the
optimisation procedure.ing to the average of the highest values of peak areas at a concentration
temperature of the evaporation step (after derv.)
(40 C) HFBA (40 C) AA (50 C) PA (50 C)
40 C 20 min 40 C 25 min 55 C 25 min 70 C
70 C 25 min 55 C 20 min 40 C 25 min 70 C
55 C 20 min 40 C 25 min 55 C 25 min 55 C
55 C 25 min 70 C 25 min 55 C 25 min 70 C
55 C 20 min 40 C 25 min 55 C 25 min 70 C
55 C 20 min 40 C 25 min 70 C 25 min 70 C
55 C 20 min 40 C 15 min 70 C 25 min 70 C
70 C 25 min 55 C 25 min 70 C 25 min 70 C
70 C 25 min 55 C 15 min 70 C 25 min 70 C
55 C 20 min 55 C 25 min 70 C 25 min 70 C
This journal is © The Royal Society of Chemistry 2017
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View Article OnlineFor ISDs, the procedure outlined in the linearity study
was used.
GC-MS conditions
Gas chromatography-mass spectrometry (GC-MS) was carried
out using a 7890A GC/5975C MSD equipped with a split/
splitless inlet and a DB-5ms (5% phenyl/95 methylsiloxane;
30 m  0.25 mm, 0.25 mm lm thickness) separation column
(All Agilent Technologies, Waldbronn, Germany). Helium was
used as a carrier gas (99.99% purity). Splitless injection at
225 C was employed. The MS transfer line temperature wasTable 5 Examination of the quality of (R2) in the target ions of selected
elution in chromatograms (tR)
Compound with ISDs/derv. PFPA (R2) TFA (R2)
Flephedrone–ISD mephadrone d3 0.998
a 0.999a
Flephedrone–ISD methylone d3 0.996 0.999
Flephedrone–ISD butylone d3 0.997 1.000
Flephedrone–ISD ethylone d5 0.995 0.990
Flephedrone–ISD MDPV d8 0.994 0.998
Mephadrone–ISD mephadrone d3 0.999
a 0.999a
Mephadrone–ISD methylone d3 0.997 0.997
Mephadrone–ISD butylone d3 0.997 0.996
Mephadrone–ISD ethylone d5 0.995 0.996
Mephadrone–ISD MDPV d8 0.994 0.989
Pentedrone–ISD mephadrone d3 0.998
a 0.998a
Pentedrone–ISD methylone d3 0.995 0.995
Pentedrone–ISD butylone d3 0.995 0.995
Pentedrone–ISD ethylone d5 0.994 0.995
Pentedrone–ISD MDPV d8 0.994 0.988
Methadrone–ISD mephadrone d3 1.000
a 0.999a
Methadrone–ISD methylone d3 0.996 1.000
Methadrone–ISD butylone d3 0.994 0.999
Methadrone–ISD ethylone d5 0.998 0.999
Methadrone–ISD MDPV d8 0.996 0.996
Methylone–ISD mephadrone d3 0.998 0.999
Methylone–ISD methylone d3 0.999
a 0.999a
Methylone–ISD butylone d3 0.999 0.999
Methylone–ISD ethylone d5 0.999 0.998
Methylone–ISD MDPV d8 0.993 0.998
Butylone–ISD mephadrone d3 0.997 0.999
Butylone–ISD methylone d3 0.999 1.000
Butylone–ISD butylone d3 0.999
a 1.000a
Butylone–ISD ethylone d5 0.999 0.999
Butylone–ISD MDPV d8 0.995 0.997
Ethylone–ISD mephadrone d3 0.994 0.999
Ethylone–ISD methylone d3 0.998 1.000
Ethylone–ISD butylone d3 0.999 1.000
Ethylone–ISD ethylone d5 0.999
a 0.999a
Ethylone–ISD MDPV d8 0.998 0.997
Pyrovalerone–ISD mephadrone d3 0.992 0.994
Pyrovalerone–ISD methylone d3 0.996 0.995
Pyrovalerone–ISD butylone d3 0.997 0.995
Pyrovalerone–ISD ethylone d5 0.997 0.994
Pyrovalerone–ISD MDPV d8 0.997
a 0.999a
MDPV–ISD mephadrone d3 0.990 0.992
MDPV–ISD methylone d3 0.996 0.993
MDPV–ISD butylone d3 0.997 0.993
MDPV–ISD ethylone d5 0.997 0.992
MDPV–ISD MDPV d8 0.999
a 0.999a
a ISD used to study validation parameters. b B.R is bad response ¼ <0.900
This journal is © The Royal Society of Chemistry 2017maintained at 250 C. The MS was operated in the electron
impact ionization mode (70 eV). The ion source was main-
tained at 200 C. MS data acquisition was initiated at 7
minutes and was performed in selected ion monitoring (SIM)
mode and scan mode. The column temperature program was
initially started at 70 C and then increased by 10 C per
minute to reach 280 C with a nal hold time of 23 minutes.
The mass spectrometer was operated in full scan mode (m/z
40–500) to study ion and peak interference. Selected ion
monitoring (SIM) mode was used to study the linearity, limit of
detection (LOD), recoveries, and peak areas.internal standards of each drug. All drugs are listed according to their
CLF2AA (R
2) HFBA (R2) AA (R2) PA (R2)
B.R 0.998a 0.997a 0.999a
0.999a B.Rb 0.990 0.991
0.999 0.995 0.995 B.R
0.995 B.R B.R B.R
B.R 0.996 0.991 0.999
B.R 0.999a 0.997a 1.000a
0.997a B.R 0.942 0.995
1.000 0.994 0.959 B.R
0.998 B.R B.R B.R
B.R 0.994 0.941 0.988
B.R 0.998a 0.997a 0.997a
0.997a B.R 0.955 0.978
0.997 0.997 0.967 B.R
0.994 B.R B.R B.R
B.R 0.998 0.954 0.986
B.R 1.000a 0.999a 0.996
0.999a 0.999 0.999 0.999a
1.000 0.996 0.999 B.R
0.998 B.R B.R B.R
B.R B.R 0.999 0.997
B.R 0.998 0.999 0.995
0.998a 0.999a 0.998a 1.000a
1.000 0.998 0.999 B.R
0.999 B.R B.R B.R
B.R B.R 0.997 0.997
B.R 0.996 0.999 0.996
0.995 0.999 0.997 1.000a
0.999a 1.000a 1.000a B.R
0.997 B.R B.R B.R
B.R B.R 0.996 0.996
B.R B.R 0.995 0.996
0.996 0.942 0.998 1.000a
0.999 0.978a 0.994a B.R
0.999a B.R B.R B.R
B.R B.R 0.997 0.996
B.R 0.998 0.995 0.986
0.997 0.997 0.998 0.998
0.996a 0.996a 0.994 B.R
0.992 B.R B.R B.R
B.R B.R 0.998a 0.994a
B.R 0.998 0.995 0.982
B.R 0.993 0.995 0.996
0.909a 0.994a 0.988 B.R
B.R B.R B.R B.R
B.R B.R 0.995a 1.000a
.
Anal. Methods, 2017, 9, 2732–2743 | 2737
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View Article OnlineResults and discussion
Fragment ions and relative ion intensities
The observed fragment ions and relative ion intensities for the
diﬀerent cathinone derivatives are summarised in Table 2. The
target ions in bold were used to calculate accuracy and RSD
values. The highest abundance ion values were used to calculate
the peak area values.
Temperature, reaction time, and three way ANOVA study
The optimum temperature and reaction time for each
compound using each reagent are shown in Table 3.
The optimum time and temperature in Table 3 were
chosen for the mixture of synthetic cathinones to develop
a method that works for the drug substances in each reagent.
Therefore, the combination of information from Tables 3 and
4 illustrates the optimal conditions for reagents and drugs.
Using the PFPA derivative of ephedrone as an example, the
reaction conditions of RT for 20 min duration were chosen
from Table 3 in combination with the ANOVA results from
Table 4.
The optimal derivatization conditions for each compound
were chosen according to the average of the highest values of
peak areas at a concentration of 0.50 mg ml1.
The peak area values of the target ions of cathinones were
more evident using reaction conditions of 25 minutes at
70 C with the exception of PFPA and TFA derivativesTable 6 Accuracy and precision, *the mean is the average of the highes
ml1
Derv./drug name PFPA TFA
Flephedrone Mean* 2 283 223 1 178 147
RSD (%) 4.07% 3.41%
Accuracy 1.81% 9.8%
Mephedrone Mean 4 467 040 3 657 740
RSD (%) 1.96% 0.99%
Accuracy 4.79% 3.47%
Pentedrone Mean 2 714 988 1 860 552
RSD (%) 1.51% 2.37%
Accuracy 10% 4.09%
Methedrone Mean 7 144 720 6 822 530
RSD (%) 4.49% 2.89%
Accuracy 5.62% 12%
Methylone Mean 6 296 421 9 973 042
RSD (%) 1.46% 1.76%
Accuracy 11% 1.11%
Butylone Mean 5 835 783 5 881 945
RSD (%) 1.96% 7.6%
Accuracy 3.28% 13%
Ethylone Mean 4 630 147 4 161 097
RSD (%) 1.14% 1.81%
Accuracy 2.09% 12%
Pyrovalerone Mean 5 801 857 2 929 385
RSD (%) 12% 1.01%
Accuracy 13% 15%
MDPV Mean 4 735 925 3 709 708
RSD (%) 14% 2.54%
Accuracy 9.5% 7.5%
2738 | Anal. Methods, 2017, 9, 2732–2743which showed excellent responses from RT derivatisation
conditions. It should be noted that AA and PA are preferable
for most of the cathinones when a high temperature of 70 C
is applied. The cathinones generally require high tempera-
tures for most of the derivatisation reagents which may be
due to properties including the boiling point of each reagent
and its molecular weight. It may be concluded that the higher
the boiling points of reagents the higher the temperatures for
reactions. PA, AA, HFBA, CLF2AA, TFA and PFPA have the
boiling points of 167 C, 139.8 C, 120 C, 96–97 C, 72.4 C,
and 69–70 C, respectively. Mephedrone and ephedrone are
more volatile compounds than other drugs because they have
a lower molecular weight. However, the responses are
improved when the reaction occurs at high temperatures
when PFPA and TFA were excluded.
Due to the high boiling point (198 C) of butyric
anhydride the reaction is not successful at 70 C. The excess
reagent is not evaporated under nitrogen even when the
temperature is higher than 70 C for 20 minutes. Additionally,
this reagent provided a poor response for all compounds
except when applied at a high concentration (5 mg ml1).
For the above reasons this reagent was not investigated
further.
The R programming language was used to perform a three-
way ANOVA considering three factors (temperature and
reaction time during incubation and the temperature of the
hot block during the evaporation step) as independentt peak area values of quantiﬁcation ions at a concentration of 0.50 mg
ClF2AA HFBA AA PA
1 881 598 3 563 229 2 407 035 1 263 952
10% 14% 1.13% 5.5%
19% 4.83% 3.67% 1.81%
3 698 786 3 702 338 1 086 728 2 523 269
6.4% 2.02% 2.71% 11%
12% 0.36% 9.0% 12%
368 017 2 582 720 2 145 452 3 099 143
2.20% 4.33% 2.59% 12%
9.3% 11% 9.3% 10%
6 657 846 6 353 019 574 827 2 489 097
4.43% 7.7% 2.59% 0.18%
7.1% 13% 5.2% 12%
5 487 420 3 591 150 2 099 231 1 157 643
0.45% 0.98% 1.76% 0.06%
12% 2.55% 6.8% 1.42%
5 132 108 4 476 375 2 139 855 5 185 680
8.2% 9.7% 2.43% 5.6%
16% 7.5% 8.5% 3.28%
4 026 282 1 914 781 63 541.29 5 185 680
7.9% 6.8% 3.82% 5.6%
9.0% 14% 17% 0.44%
5 626 518 7 895 943 6 658 780 4 976 504
4.74% 6.8% 10% 12%
19% 14% 3.43% 13%
4 519 016 6 421 153 4 600 039 5 523 840
10% 11% 12% 15%
16% 19% 0.39% 5.8%
This journal is © The Royal Society of Chemistry 2017
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View Article Onlinevariables. The dependent variables (54 diﬀerent ANOVA ¼ 9
drugs  6 reagents) were the mean of peak area values at each
specic time and temperature for each drug and for each
derivatisation reagent alone (5184 tests of peak area values
were produced; 5184 tests ¼ 8 days  72 samples per day  9
drugs). In order to infer that there was a diﬀerence in the
results it was expected to see at least one of the
three independent variables to appear as statistically
signicant within the 5% level of condence. If the proba-
bility factor (F) was higher than 5%, this means that the
diﬀerence between peak area values, produced by altering the
three variables noted above, was statistically signicant. The
data in Table 4 demonstrate that we should run the sample
under a strict procedure or under specic conditions if there
is signicant diﬀerence (yes) in the derivatised drug. For
example, the samples should follow the optimised procedure
in the case of ephedrone and mephedrone derivatised by
PFPA to get the best response; if not the peak area values
will signicantly change above the 95% condence limit
then, as the consequence will give a bad response. In the case
of TFA derivatisation, the probabilities for all drugs to give
the same values of peak areas even with changes in time or
temperature within the 95% limit condence are signi-
cantly the same. Therefore, many incubation times and
temperatures are appropriate for this reagent. All substances
derivatised with PA should follow the optimised procedure
specically the temperature of the hot block in the evapora-
tion step. PA samples may need more than an hour to evap-
orate at RT.
The uncertainty studies may require answering the question:
why do we have no signicant diﬀerences?
It may be the eﬀects of many factors such as losing
the drug during the evaporation step or as a result of
thermal decomposition of derivatised drugs in the injector
port.16Table 8 Recovery studies
Drug name/derv. PFPA TFA ClF2AA HFBA AA
Flephedrone Recovery 69% 69% 100% 59% 81%
RSD (%) 7.4% 12% 17% 6.2% 2.14%
Mephedrone Recovery 107% 104% 94% 64% 121%
RSD (%) 7.1% 1.43% 9.7% 20% 7.6%
Pentedrone Recovery 70% 112% 92% 43% 68%
RSD (%) 2.63% 3.48% 17% 20% 5.2%
Methedrone Recovery 107% 129% 100% 110% 94%
RSD (%) 9.6% 7.9% 7.5% 19% 10%
Methylone Recovery 101% 98% 98% 126% 82%
RSD (%) 0.75% 2.37% 3.59% 16% 2.35%
Butylone Recovery 145% 51% 37% 53% 75%
RSD (%) 5.3% 0.84% 56% 1.80% 18%
Ethylone Recovery 229% 117% 97% 14% 119%
RSD (%) 32% 1.27% 5.4% 7.3% 15%
Pyrovalerone Recovery 77% 19% 64% 52% 187%
RSD (%) 1.90% 11% 23% 15% 15%
MDPV Recovery 58% 122% 63% 134% 106%
RSD (%) 1.13% 2.86% 20% 3.76% 3.24%
Anal. Methods, 2017, 9, 2732–2743 | 2739
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View Article OnlineInternal standards, RSD and accuracy, linearities, limit of
detection, and recovery studies
The internal standard results are shown in Table 5. The purpose
of this procedure was to evaluate the application of internal
standards.
 Can we use one or two internal standards (ISDs) for all
studied cathinones?
 Which ISD has the best-t regression?
To answer the above points, we applied each of the ve
internal standards to all nine drugs. All internal standards
worked well and gave more than 0.990 when PFPA and TFA were
applied. The ISDs that gave a poor response were avoided in all
experiments.
The RSD (%), accuracy, linearity, LOD and recovery data were
only calculated according to optimal conditions.
The RSD (%) values were calculated from the procedure of
optimal methods only (the mean of SDO the mean of peak area
ratio)  100 at a concentration of 0.5 mg ml1. According to the
RSD values of peak areas at 0.5 mg ml1, the best results were
given by ClF2AA followed by PFPA then AA, HFBA, TFA and PA
respectively.
The accuracy values were calculated from (the mean of
calculation of concentration – true valuesO true values)  100
at a concentration of 0.5 mg ml1. The best results were given by
PFPA then HFBA, TFA, PA, CLF2AA and lastly AA. The anhy-
drides proved to be suitable for cathinone derivatization
because none exceeded 20% for both RSD and accuracy, which
is recommended in ref. 14 (see Table 6).
Linear correlation coeﬃcients (R2) were calculated from the
triplicate samples at seven concentrations (2, 1, 0.75, 0.5, 0.25,
0.1, and 0.05 mg ml1). All R2 values were greater than 0.905. The
best results were obtained with PFPA and HFBA; all values were
higher than 0.998 followed by PA, AA, TFA, and then ClF2AA
(pyrovalerone and MDPV were excluded).
The LOD was measured in SIM mode using methanol spiked
with mixtures of cathinones in the range of 1 to 250 ng ml1.
The signal-to-noise (S/N) ratio was calculated from triplicateFig. 2 Fragmentation patterns for each substance applied to selected re
methods were used to show the fragmentation patterns.
2740 | Anal. Methods, 2017, 9, 2732–2743measurements at seven concentrations (250, 100, 50, 25, 10, 5,
and 1 ng ml1). The lowest concentration at which the S/N was
greater than 3 was considered to be the LOD. PFPA, PA, TFA,
HFBA, CLF2AA, and AA provided the best results respectively
(see Table 7).
The recovery study was completed to check that all drugs
can be derivatised aer extraction of whole blood. Relative
recoveries were calculated using a concentration of 3 mg
ml1. The samples were extracted three times without
internal standards present until addition prior to the evap-
oration step under nitrogen. At the same time three un-
extracted standards were prepared at 3 mg ml1 with
internal standards. The recovery of each drug was calculated
using the following equation: recovery% ¼ (peak area ratio of
extracted standards O peak area ratio of un-extracted stan-
dards)  100. The recovery results with precision are shown
in Table 8.Study of interference, fragmentation patterns and the highest
peak area values
Mixtures of nine cathinones were examined to study the frag-
mentation pattern (Fig. 2) and interference (Fig. 3). No co-
elution problems were observed except in two cases: butylone
could not be separated eﬀectively from ethylone if they were
derivatized with AA and PA. However, ethylone has a unique ion
allowing the compounds to be distinguished from each other.
Butylone and ethylone have the same M.W.; the diﬀerences
between the fragmentation patterns were discussed by
Kerrigan.16
A number of fragmentation ions were studied for the drugs
in each reagent. In general AA followed by PA then HFBA, PFPA,
TFA and CLF2AA respectively give the maximum abundance
ions based on ion intensities and greater fragmentation
patterns than other reagents (see Fig. 2).
The highest abundance ion values were used to calculate the
peak areas. These ions were chosen instead of target ions
(quantication ions) because we need to compare the ions thatagents. Less than 10% fragmentation ions were deleted. The optimised
This journal is © The Royal Society of Chemistry 2017
Fig. 3 Chromatograms for three diﬀerent acetylation derivatives of synthetic cathinones at a concentration of 0.50 mg ml1 and blank blood
sample.
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View Article Onlinegive 100% of abundance in the background of fragmentation
ions for six diﬀerent reagents. Each one of the reagents has
diﬀerent ions and so we should apply all of them with the same
relative ion intensity (100%), as illustrated in Fig. 4. All valid
results for derivatised drugs aer optimising conditions have
good peak areas excluding AA for ethylone and methedrone as
well CLF2AA for pentedrone.Overview
Table 9 shows which reagent provides the best results under
diﬀerent factors. For example, if a screening method suggestsThis journal is © The Royal Society of Chemistry 2017the presence of ephedrone is positive, we should use TFA for
quantication methods due to the following reasons:
 Good fragmentation patterns are evident.
 High quality fragmentation ions are present.
 High response is observed compared to the main ion or
remaining ions.
 It has the largest number of unique ions and ions in total.
 It is valid in linearity, accuracy and precision.
The example above can be applied to all gures using
a similar explanation.Anal. Methods, 2017, 9, 2732–2743 | 2741
Fig. 4 Mean of the highest peak area values in selected compounds and agents. The optimised methods were used in this calculation.
Table 9 Favoured reagents for each drug depending on selected parameters
Drug name
Ratio
between
all ions
No. of
unique ions
No. of
ions LOD Linearity RSD Accuracy
The
highest
peak area
Evaporation
25 C
aer derv.
Evaporation
50 C
aer derv.
Flephedrone TFA TFA, CLF2A TFA, HFBA PFPA,
HFBA
All t Valid Valid HFBA/AA Valid Bad response
Mephedrone AA PFPA, HFBA,
TFA, CLF2A
HFBA PFPA,
HFBA
All t Valid Valid PFPA/HFBA Valid Bad response
Pentedrone TFA HFBA, AA PFPA PFPA,
HFBA,
AA
All t Valid Valid PA/PFPA Valid Bad response
Methedrone PA HFBA, AA HFBA PFPA All t Valid Valid PFPA/TFA Valid Bad response
Methylone AA HFBA,
CLF2AA,
AA, PA
HFBA PFPA,
TFA,
PA
All t Valid Valid TFA/PFPA Valid Bad response
Butylone AA No one HFBA, PA All except
CLF2AA
and AA
All t Valid Valid TFA/PFPA Valid Valid
Ethylone PFPA All PA PFPA, PA All t Valid Valid PA/PFPA Valid Valid
Pyrovalerone Underivatized Underivatized Underivatized PA PA PA PA HFBA/AA Bad response Valid
MDPV Underivatized Underivatized Underivatized PA PA PA PA HFBA/AA Bad response Valid
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View Article OnlineConclusion
The mass spectra of nine synthetic cathinones were compared
to one another aer derivatization with a number of diﬀerent
acylation reagents (PFPA, TFA, CLF2AA, HFBA, AA and PA). The
optimisation of conditions for the incubation time and reac-
tion temperature was discussed, and all anhydrides tested
proved to be suitable for synthetic cathinones with RSD and
accuracy below 20% under the optimised conditions for the
reagents. The independent variables were assessed using
a three-way ANOVA approach and demonstrated that the
procedure should be strictly followed for combinations of
drugs and reagents. In this paper, we have shown that one or
two ISDs may be suﬃcient to provide good linearity in the
mixture of cathinones chosen. The overview section shows2742 | Anal. Methods, 2017, 9, 2732–2743some suggestions of which reagent can be chosen for each
compound and applied to quantication or semi-
quantication methods only. In general, PFPA and HFBA, fol-
lowed by TFA, are the best choice of derivatising agents.
Therefore, our future aim will be to fully validate a method
using PFPA. MDPV and pyrovalerone are tertiary amines that
were not derivatized with reagents tested. Therefore, we can
conclude that several combinations of cathinones and deriva-
tization reagents are suitable for GC-MS analysis.Acknowledgements
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